Trials / Completed
CompletedNCT04438928
Clinical Study on the Effect of Elevit Pregnancy 2nd & 3rd Trimester (Multi-micronutrients & DHA Supplement) on the Nutritional Status of Pregnant Women During Second and Third Trimester
Effects of Multiple Micronutrients and Docosahexaenoic Acid (DHA) Supplementation During Pregnancy on Maternal Biomarkers and Infant Anthropometric Outcomes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 164 (actual)
- Sponsor
- Bayer · Industry
- Sex
- Female
- Age
- 18 Years – 42 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to collect information how adding a soft gel preparation of micronutrients such as vitamins, dietary minerals plus omega-3 fatty acid (docosahexaenoic acid, DHA) to the diet of pregnant women during the 2nd and 3rd trimesters of pregnancy effects the nutritional state of the mother and infants at delivery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Elevit Pregnancy 2nd & 3rd Trimester | Once daily micronutrient plus DHA supplementation (Multi-micronutrients and docosahexaenoic acid (MMS) soft gel capsules) |
| OTHER | Non-Supplement | Control study group of pregnant women non-supplemented with multi-micronutrients and docosahexaenoic acid (MMS) soft gel capsules |
Timeline
- Start date
- 2016-09-27
- Primary completion
- 2019-12-05
- Completion
- 2019-12-05
- First posted
- 2020-06-19
- Last updated
- 2020-11-16
Locations
2 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT04438928. Inclusion in this directory is not an endorsement.